AJANTA PHARMA
|
AJANTA PHARMA Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹7,979 Cr | ₹7,168 Cr | ₹3,396 Cr | ₹2,950 Cr | ₹2,588 Cr |
| Sales | ₹7,932 Cr | ₹7,133 Cr | ₹3,339 Cr | ₹2,905 Cr | ₹2,559 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | - | - | - | - | - |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹47 Cr | ₹35 Cr | ₹57 Cr | ₹44 Cr | ₹29 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹4,209 Cr | ₹3,743 Cr | ₹3,341 Cr | ₹2,890 Cr | ₹2,588 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-39 Cr | ₹26 Cr | ₹-83 Cr | ₹-151 Cr | ₹-17 Cr |
| Raw Material Consumed | ₹919 Cr | ₹844 Cr | ₹761 Cr | ₹666 Cr | ₹555 Cr |
| Opening Raw Materials | ₹264 Cr | ₹240 Cr | ₹291 Cr | ₹175 Cr | ₹151 Cr |
| Purchases Raw Materials | ₹722 Cr | ₹722 Cr | ₹574 Cr | ₹693 Cr | ₹467 Cr |
| Closing Raw Materials | ₹233 Cr | ₹264 Cr | ₹240 Cr | ₹291 Cr | ₹175 Cr |
| Other Direct Purchases / Brought in cost | ₹166 Cr | ₹146 Cr | ₹136 Cr | ₹90 Cr | ₹112 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹67 Cr | ₹66 Cr | ₹54 Cr | ₹44 Cr | ₹39 Cr |
| Electricity & Power | ₹67 Cr | ₹66 Cr | ₹54 Cr | ₹44 Cr | ₹39 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹900 Cr | ₹785 Cr | ₹646 Cr | ₹548 Cr | ₹486 Cr |
| Salaries, Wages & Bonus | ₹826 Cr | ₹731 Cr | ₹597 Cr | ₹500 Cr | ₹447 Cr |
| Contributions to EPF & Pension Funds | ₹36 Cr | ₹34 Cr | ₹31 Cr | ₹29 Cr | ₹26 Cr |
| Workmen and Staff Welfare Expenses | ₹12 Cr | ₹12 Cr | ₹10 Cr | ₹13 Cr | ₹7.36 Cr |
| Other Employees Cost | ₹26 Cr | ₹7.98 Cr | ₹7.37 Cr | ₹6.79 Cr | ₹5.30 Cr |
| Other Manufacturing Expenses | ₹303 Cr | ₹321 Cr | ₹275 Cr | ₹226 Cr | ₹205 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | ₹14 Cr | ₹14 Cr | ₹15 Cr | ₹21 Cr | ₹18 Cr |
| Repairs and Maintenance | ₹54 Cr | ₹60 Cr | ₹52 Cr | ₹38 Cr | ₹34 Cr |
| Packing Material Consumed | ₹186 Cr | ₹181 Cr | ₹155 Cr | ₹130 Cr | ₹118 Cr |
| Other Mfg Exp | ₹49 Cr | ₹66 Cr | ₹54 Cr | ₹37 Cr | ₹35 Cr |
| General and Administration Expenses | ₹382 Cr | ₹366 Cr | ₹301 Cr | ₹132 Cr | ₹159 Cr |
| Rent , Rates & Taxes | ₹8.81 Cr | ₹9.21 Cr | ₹8.21 Cr | ₹3.98 Cr | ₹3.30 Cr |
| Insurance | ₹16 Cr | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹7.79 Cr |
| Printing and stationery | - | - | - | - | - |
| Professional and legal fees | ₹151 Cr | ₹132 Cr | ₹118 Cr | ₹38 Cr | ₹51 Cr |
| Traveling and conveyance | ₹143 Cr | ₹117 Cr | ₹86 Cr | ₹34 Cr | ₹56 Cr |
| Other Administration | ₹64 Cr | ₹92 Cr | ₹74 Cr | ₹41 Cr | ₹41 Cr |
| Selling and Distribution Expenses | ₹418 Cr | ₹464 Cr | ₹400 Cr | ₹375 Cr | ₹414 Cr |
| Advertisement & Sales Promotion | ₹4.49 Cr | ₹5.02 Cr | ₹4.78 Cr | ₹1.62 Cr | ₹1.40 Cr |
| Sales Commissions & Incentives | - | - | - | - | - |
| Freight and Forwarding | - | - | - | - | - |
| Handling and Clearing Charges | ₹164 Cr | ₹237 Cr | ₹182 Cr | ₹136 Cr | ₹109 Cr |
| Other Selling Expenses | ₹249 Cr | ₹222 Cr | ₹214 Cr | ₹237 Cr | ₹303 Cr |
| Miscellaneous Expenses | ₹87 Cr | ₹89 Cr | ₹57 Cr | ₹52 Cr | ₹64 Cr |
| Bad debts /advances written off | ₹0.06 Cr | ₹0.02 Cr | ₹3.98 Cr | - | - |
| Provision for doubtful debts | - | - | - | - | - |
| Losson disposal of fixed assets(net) | - | ₹6.19 Cr | ₹3.87 Cr | ₹2.21 Cr | ₹0.10 Cr |
| Losson foreign exchange fluctuations | - | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹87 Cr | ₹82 Cr | ₹49 Cr | ₹49 Cr | ₹64 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹3,037 Cr | ₹2,959 Cr | ₹2,412 Cr | ₹1,891 Cr | ₹1,905 Cr |
| Operating Profit (Excl OI) | ₹1,172 Cr | ₹783 Cr | ₹929 Cr | ₹999 Cr | ₹683 Cr |
| Other Income | ₹85 Cr | ₹99 Cr | ₹116 Cr | ₹26 Cr | ₹92 Cr |
| Interest Received | ₹28 Cr | ₹8.46 Cr | ₹15 Cr | ₹3.51 Cr | ₹1.06 Cr |
| Dividend Received | - | - | - | - | ₹3.35 Cr |
| Profit on sale of Fixed Assets | ₹3.49 Cr | ₹0.84 Cr | - | - | - |
| Profits on sale of Investments | ₹11 Cr | ₹17 Cr | ₹3.07 Cr | - | - |
| Provision Written Back | - | - | - | - | - |
| Foreign Exchange Gains | ₹16 Cr | ₹66 Cr | ₹56 Cr | ₹4.51 Cr | ₹75 Cr |
| Others | ₹26 Cr | ₹6.15 Cr | ₹42 Cr | ₹18 Cr | ₹13 Cr |
| Operating Profit | ₹1,257 Cr | ₹882 Cr | ₹1,045 Cr | ₹1,025 Cr | ₹776 Cr |
| Interest | ₹7.21 Cr | ₹5.84 Cr | ₹10 Cr | ₹8.27 Cr | ₹12 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | ₹7.21 Cr | ₹5.84 Cr | ₹10 Cr | ₹8.27 Cr | ₹12 Cr |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | - | - | - | - | - |
| Other Interest | - | - | - | - | - |
| PBDT | ₹1,249 Cr | ₹876 Cr | ₹1,035 Cr | ₹1,016 Cr | ₹764 Cr |
| Depreciation | ₹135 Cr | ₹131 Cr | ₹125 Cr | ₹116 Cr | ₹96 Cr |
| Profit Before Taxation & Exceptional Items | ₹1,114 Cr | ₹745 Cr | ₹909 Cr | ₹900 Cr | ₹668 Cr |
| Exceptional Income / Expenses | - | - | - | - | ₹-3.92 Cr |
| Profit Before Tax | ₹1,114 Cr | ₹745 Cr | ₹909 Cr | ₹900 Cr | ₹664 Cr |
| Provision for Tax | ₹298 Cr | ₹157 Cr | ₹197 Cr | ₹246 Cr | ₹196 Cr |
| Current Income Tax | ₹298 Cr | ₹176 Cr | ₹217 Cr | ₹270 Cr | ₹185 Cr |
| Deferred Tax | ₹-27 Cr | ₹-37 Cr | ₹4.94 Cr | ₹-13 Cr | ₹9.92 Cr |
| Other taxes | ₹27 Cr | ₹19 Cr | ₹-25 Cr | ₹-10 Cr | ₹0.91 Cr |
| Profit After Tax | ₹816 Cr | ₹588 Cr | ₹713 Cr | ₹654 Cr | ₹468 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | - | - | - | - | - |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹816 Cr | ₹588 Cr | ₹713 Cr | ₹654 Cr | ₹468 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹3,141 Cr | ₹2,718 Cr | ₹2,156 Cr | ₹1,617 Cr | ₹1,270 Cr |
| Appropriations | ₹3,957 Cr | ₹3,306 Cr | ₹2,868 Cr | ₹2,271 Cr | ₹1,737 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | ₹2.50 Cr |
| Other Appropriation | ₹0.92 Cr | ₹75 Cr | ₹69 Cr | ₹32 Cr | ₹4.09 Cr |
| Equity Dividend % | ₹2,550.00 | ₹350.00 | ₹475.00 | ₹475.00 | ₹650.00 |
| Earnings Per Share | ₹64.83 | ₹46.70 | ₹83.45 | ₹75.59 | ₹53.60 |
| Adjusted EPS | ₹64.83 | ₹46.70 | ₹55.63 | ₹50.39 | ₹35.74 |
Compare Income Statement of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹30,143.4 Cr | -1% | -5.1% | -23.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,791.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,885.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,930.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,108.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,164.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -1% |
-5.1% |
-23.1% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses